APC and colorectal carcinoma: These alterations include loss of heterozygosity (in about 30–40% of CRC) and point mutations that lead to the expression of truncated versions of the APC protein without the C-terminal region, a critical region for β-catenin destruction complex scaffolding [5] (Figure 2).